Abstract
<p class="abstract"><strong>Background:</strong> Objective of the study was to evaluate the long term clinical performance and acceptability of levenorgestrel releasing intrauterine system (LNG-IUS), ‘Emily’, for the treatment of abnormal uterine bleeding (AUB).</p><p class="abstract"><strong>Methods:</strong> A two year feed back survey was carried out by telephonic conversation and the data obtained was fed in to the house web application system in the respective Emily users. Subjective perceptions were verbally assured based on a questionnaire framed on the quality of the life led by the Emily users. </p><p class="abstract"><strong>Results:</strong> The treatment resulted in a significant reduction in the menstrual bleeding of 102 patients who completed the two year study. The mean bleeding score and SD 18.79 (13.36) in first year falls to 10.76 (12.40) in second year. 78 (76.47%) users were very satisfied with the product usage.</p><p class="abstract"><strong>Conclusions:</strong> Use of ‘Emily’ LNG-IUS resulted in significant reduction of menstrual bleeding in women with AUB in two years and most of the users were very satisfied with the product.</p>
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
